|4.17||-0.12 / -2.80%|
As of 4:00pm ET
|4.17||0.00 / 0.00%|
The 2 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +67.87% increase from the last price of 4.17.
The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.